Abstract | OBJECTIVE: MATERIAL AND METHODS: RESULTS: Maximum symptom improvement was seen in patients treated with IVIg (67%). 6 patients (55%) had improvement in vomiting, whereas 5 patients (45%) had improvements in nausea, abdominal pain and bloating. CONCLUSIONS:
Immunomodulatory therapy shows positive outcomes in improving vomiting symptom in some gastroparetic patients who have coexisting positive autoimmune profiles. This preliminary data suggests the need for further investigations in immunotherapy targeted to patients with gastroparetic symptoms refractory to approved drug and device therapies.
|
Authors | Kaartik Soota, Archana Kedar, Yana Nikitina, Evelyn Arendale, Vetta Vedanarayanan, Thomas L Abell |
Journal | Results in immunology
(Results Immunol)
Vol. 6
Pg. 11-4
( 2016)
ISSN: 2211-2839 [Print] Netherlands |
PMID | 27014566
(Publication Type: Journal Article)
|